Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
Sinovac Biotech Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | -152.15M |
| September 30, 2020 | -30.38M |
| June 30, 2020 | -47.87M |
| March 31, 2020 | 25.65M |
| December 31, 2019 | -32.30M |
| September 30, 2019 | -3.825M |
| June 30, 2019 | -5.776M |
| March 31, 2019 | -0.557M |
| December 31, 2018 | -1.84M |
| September 30, 2018 | -20.56M |
| June 30, 2018 | -1.317M |
| March 31, 2018 | -1.542M |
| December 31, 2016 | -4.42M |
| September 30, 2016 | -3.611M |
| June 30, 2016 | -1.066M |
| March 31, 2016 | -2.679M |
| December 31, 2015 | -1.142M |
| September 30, 2015 | -0.528M |
| June 30, 2015 | -1.064M |
| March 31, 2015 | -1.781M |
| December 31, 2014 | -3.696M |
| September 30, 2014 | -1.624M |
| June 30, 2014 | -3.479M |
| March 31, 2014 | -2.204M |
| Date | Value |
|---|---|
| December 31, 2013 | -1.739M |
| September 30, 2013 | -1.205M |
| June 30, 2013 | -0.072M |
| March 31, 2013 | -2.16M |
| December 31, 2012 | -5.209M |
| September 30, 2012 | -4.322M |
| June 30, 2012 | -3.659M |
| March 31, 2012 | -2.960M |
| December 31, 2011 | 25.47M |
| September 30, 2011 | -12.67M |
| June 30, 2011 | -25.43M |
| March 31, 2011 | -1.155M |
| December 31, 2010 | -5.080M |
| September 30, 2010 | -1.115M |
| June 30, 2010 | -3.561M |
| March 31, 2010 | -9.489M |
| December 31, 2009 | -8.213M |
| September 30, 2009 | -1.718M |
| June 30, 2009 | -0.7505M |
| March 31, 2009 | -1.012M |
| December 31, 2008 | -0.6755M |
| September 30, 2008 | -0.6127M |
| June 30, 2008 | -0.2934M |
| March 31, 2008 | -2.378M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-152.15M
Minimum
Dec 2020
25.65M
Maximum
Mar 2020
-35.24M
Average
-30.38M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | -- |
| Zai Lab Ltd | 3.292M |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -3.237M |